Golden State Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101K Buy
1,098
+7
+0.6% +$612 0.01% 571
2026
Q1
$93.1K Buy
1,091
+5
+0.5% +$446 0.01% 538
2025
Q4
$85.8K Sell
1,086
-63
-5% -$4.94K 0.01% 556
2025
Q3
$91.9K Buy
1,149
+1,006
+703% +$85.8K 0.01% 527
2025
Q2
$13K Buy
143
+1
+0.7% +$91 ﹤0.01% 1003
2025
Q1
$13.4K Hold
142
﹤0.01% 913
2024
Q4
$13K Buy
+142
New +$13.6K ﹤0.01% 889
2020
Q2
Sell
-599
Closed -$40K 305
2020
Q1
$40K Buy
+599
New +$42.2K 0.02% 394
2019
Q4
Sell
-508
Closed -$37K 199
2019
Q3
$37K Hold
508
0.01% 490
2019
Q2
$36K Buy
508
+34
+7% +$2.41K 0.01% 522
2019
Q1
$32K Buy
+474
New +$30.6K 0.01% 532

Other funds holding CL

Golden State Wealth Management's CL Position: Q2 2026 in Review

Golden State Wealth Management increased its Colgate-Palmolive (CL) stake by 0.64% in Q2 2026, buying an estimated $612 and bringing the position to 1,098 shares worth $101K. The position accounts for 0.01% of the portfolio, ranked #571.

Golden State Wealth Management first reported a position in CL in Q1 2019 and has held it in 11 quarters since. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Golden State Wealth Management held 1,098 shares of Colgate-Palmolive worth $101K as of Q2 2026.
  • Golden State Wealth Management bought 7 Colgate-Palmolive shares in Q2 2026, an estimated $612.
  • Colgate-Palmolive made up 0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #571 holding.
  • Golden State Wealth Management first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 11 quarters since.
  • 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.